Science@UH

Quintin Pan, PhD, explores the surge of HPV+ related head and neck cancers sparking the need for innovative treatment solutions. About Quintin Pan, PhD Learn more about the University Hospitals Research & Education Institute Follow Us on Social:          

Mehdi Shishehbor, DO, PhD, explains how his team is developing preventative solutions to overcome chronic limb-threatening ischemia. About Mehdi Shishehbor, DO, PhD Read more about the FDA approval Learn more about the University Hospitals Research & Education Institute Follow Us on Social:          

Amitabh Chak, MD, Sanford Markowitz, MD, PhD, and Joseph Willis, MD, explain the journey of EsoCheck™ and EsoGuard™, an incredible bench to bedside diagnostic discovery to detect Barrett's esophagus and prevent esophageal cancer.

Francoise Adan, MD, and Samuel Rodgers-Melnick, MPH, MT-BC, discuss how Connor Whole Health’s research of how music therapy reduces pain, stress and anxiety and how these modalities can be implemented for patient care.

Cynthia Bearer, MD, explains how her groundbreaking research on fetal alcohol spectrum disorder, lipid rafts, and brain development in preterm babies aims to improve neonatal care.

Leonardo Kayat Bittencourt, MD, discusses how the University Hospitals Radiology AI and Diagnostic Innovation Collaborative, RadiCLE, is collaborating with innovative teams to use AI application to investigate clinical practices in hope of bringing new solutions to improve patient care and outcomes.

Sanjay Rajagopalan, MD discusses how historical government policies impact health outcomes more than 90 years later and the need to understand external and internal environments to transform the delivery of healthcare.

Jonathan Stamler, MD discusses what lead him to the discover of S-nitrosylation, the binding of nitric oxide to proteins works through allostery and how this all lead to the creation of an oxygen and nitric oxide tracking fitness monitor.

Martha Sajatovic, MD explains how her research has led to a self-management program for patients with epilepsy and science to service models for other neurological conditions.

Afshin Dowlait, MD describes how his team of researchers discovered a new non-small cell lung cancer subtype in the laboratory and brought a new treatment for this cancer subtype to patients in a clinical trial.

Endoscopic ear surgeon and pioneer, Alejandro Rivas, MD, discusses why he is driven to advance science for patients with hearing loss, the latest advances in cochlear implant surgery and his clinical trials aimed to prevent hearing loss in children and adults.

Cynthia Owusu, MD and Randy Vince, MD discuss how they were inspired through their medical and personal experiences to become physician-scientists who help to improve the social determinants of health and health disparities for African American men and women with prostate and breast cancers.

Fabio Cominelli, MD discusses how his team of researchers discovered the specific blockade of interleukin-18 can reduce disease severity in colitis and new personalized therapies to put IBD in permanent remission.

Sadeer Al-Kindi, MD and Ian Neeland, MD discuss CINEMA, a center of excellecence that advances clinical excellence, promotes team science, and impacts the standard of care for patients with cardiometabolic disease.

Grace McComsey, MD, Vice President of Research and Associate Chief Scientific Officer at University Hospitals discusses how University Hospitals acted fast and became a vital academic center during the pandemic to better understand the COVID-19 virus and treatments through a multitude of clinical and research studies.

Led by Michael DeGeorgia, MD and Kenneth Loparo, PhD, a $1.2 million JobsOhio grant will help establish the Center for Connected Health Innovation to enhance precision medicine in the ICU.

Rose Gubitosi-Klug, MD discusses pediatric type 1 diabetes and the evolution of standard care and daily management.

Jordan Winter, MD discusses his research breakthroughs to identify a metabolic enzyme, IHD1, in pancreatic cancer and how this led to finding a drug developed for other cancers that can also target this wild-type enzyme of pancreatic cancer.

Daniel Spratt, MD discusses the obstacles of prostate cancer and shares breakthroughs and achievements.